Nanomedicine and Onco-Immunotherapy: From the Bench to Bedside to Biomarkers

Nanomedicine and Onco-Immunotherapy: From the Bench to Bedside to Biomarkers

The broad relationship between the immune system and cancer is opening a new hallmark to explore for nanomedicine. Here, all the common and synergy points between both areas are reviewed and described, and the recent approaches which show the progress from the bench to the beside to biomarkers devel...

Full description

Bibliographic Details
Main Authors: Vanessa Acebes-Fernández, Alicia Landeria-Viñuela, Pablo Juanes-Velasco, Angela-Patricia Hernández, Andrea Otazo-Perez, Raúl Manzano-Román, Rafael Gongora, Manuel Fuentes
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Nanomaterials
Subjects:
nanomaterials
nanomedicine
immunotherapy
oncotherapy
immune-checkpoint inhibitors
immunogenic cell death
Online Access:https://www.mdpi.com/2079-4991/10/7/1274

Internet

https://www.mdpi.com/2079-4991/10/7/1274

Similar Items